Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk?: CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Philip J. Barter; Stephen J. Nicholls; John J.P. Kastelein; Kerry Anne Rye

doi:10.1161/CIRCULATIONAHA.114.014025

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

Philip J. Barter, Stephen J. Nicholls, John J.P. Kastelein, Kerry Anne Rye

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	423-432
Number of pages	10
Journal	Circulation
Volume	132
Issue number	5
DOIs	https://doi.org/10.1161/CIRCULATIONAHA.114.014025
Publication status	Published or Issued - 4 Aug 2015
Externally published	Yes

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Access to Document

10.1161/CIRCULATIONAHA.114.014025

Cite this

@article{c57550c8c9884eb69e78e7017baf99e6,

title = "Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk?: CETP inhibition as a strategy to reduce cardiovascular risk: The pro case",

author = "Barter, {Philip J.} and Nicholls, {Stephen J.} and Kastelein, {John J.P.} and Rye, {Kerry Anne}",

year = "2015",

month = aug,

day = "4",

doi = "10.1161/CIRCULATIONAHA.114.014025",

language = "English",

volume = "132",

pages = "423--432",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case. / Barter, Philip J.; Nicholls, Stephen J.; Kastelein, John J.P. et al.
In: Circulation, Vol. 132, No. 5, 04.08.2015, p. 423-432.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk?

T2 - CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

AU - Barter, Philip J.

AU - Nicholls, Stephen J.

AU - Kastelein, John J.P.

AU - Rye, Kerry Anne

PY - 2015/8/4

Y1 - 2015/8/4

UR - http://www.scopus.com/inward/record.url?scp=84939524337&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.114.014025

DO - 10.1161/CIRCULATIONAHA.114.014025

M3 - Article

C2 - 26240263

AN - SCOPUS:84939524337

SN - 0009-7322

VL - 132

SP - 423

EP - 432

JO - Circulation

JF - Circulation

IS - 5

ER -

Is cholesteryl ester transfer protein inhibition an effective strategy to reduce cardiovascular risk? CETP inhibition as a strategy to reduce cardiovascular risk: The pro case

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this